Zobrazeno 1 - 10
of 54
pro vyhledávání: '"ShanQi Guo"'
Autor:
Yao Zhang, Shanqi Guo, Chaoran Wang, Xiaodi Liu, Yan Liu, Hongcai Shang, Peiying Yang, Liang Wang, Jingbo Zhai, Xiaojiang Li, Yingjie Jia
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-10 (2022)
Abstract Background Urinary incontinence is a common complication post radical prostatectomy. Acupuncture is considered an effective treatment for post-prostatectomy incontinence (PPI), but the evidence is still limited. We propose to evaluate the ef
Externí odkaz:
https://doaj.org/article/f6875af617214f3a8eac97ec87c187c2
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Recent evidence has shown that the induction of ferroptosis is a new therapeutic strategy for advanced prostate cancer (PCa) when used as a monotherapy or in combination with second-generation antiandrogens. However, whether ferroptosis inducers are
Externí odkaz:
https://doaj.org/article/229a2ace11f04786b9b92086f25d2a26
Autor:
Yangyi Zhang, Shanqi Guo, Shuo Wang, Xiaojian Li, Dingkun Hou, Hongzheng Li, Lili Wang, Yong Xu, Baojie Ma, Haitao Wang, Xingkang Jiang
Publikováno v:
Ecotoxicology and Environmental Safety, Vol 220, Iss , Pp 112376- (2021)
Previous studies suggest that cadmium (Cd) is one of the causative factors of prostate cancer (PCa), but the effect of chronic Cd exposure on PCa progression remains unclear. Besides, whether long noncoding RNAs (lncRNAs) are involved in the regulati
Externí odkaz:
https://doaj.org/article/55027cb369eb4a9ca1ac1ac1d3ad81a7
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
Astragalus polysaccharides (APS) is a traditional Chinese medicine and have been proved to involve in multiple biological processes, including inflammation, metabolism, and carcinogenics. However, the specific mechanisms by which APS on prostate canc
Externí odkaz:
https://doaj.org/article/131b2bd1e6e84002855622a105bd3e27
Publikováno v:
Molecular Cancer Research. 21:472-482
Emerging evidence has suggested that patients with metastatic prostate cancer will become resistant after receiving docetaxel (DTX) chemotherapy, but the specific regulatory mechanism is still unclear. lincROR is an important oncogenic long noncoding
Emerging evidence has suggested that patients with metastatic prostate cancer will become resistant after receiving docetaxel (DTX) chemotherapy, but the specific regulatory mechanism is still unclear. lincROR is an important oncogenic long noncoding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de9a43a7e190d8394064fc19746e733d
https://doi.org/10.1158/1541-7786.c.6545826.v2
https://doi.org/10.1158/1541-7786.c.6545826.v2
S1. A. CCK-8 assay was used to detect the cytotoxicity of DTX in DTX-resistant PCa cells (PC3/DR and DU145/DR) and their parental sensitive cells (PC3 and DU145). B. The list of hypoxia-related lncRNAs from Pubmed and the top 80 upregulated lncRNAs i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::092406086264f785679dec1d0c7a17d3
https://doi.org/10.1158/1541-7786.22528977
https://doi.org/10.1158/1541-7786.22528977
Autor:
Yong Xu, Yuanjie Niu, Ranlu Liu, Yong Wang, Haojie Chen, Yangyi Zhang, Shuo Wang, Shanqi Guo, Xingkang Jiang
Supplementary Figure from EIF4A3-Induced circARHGAP29 Promotes Aerobic Glycolysis in Docetaxel-Resistant Prostate Cancer through IGF2BP2/c-Myc/LDHA Signaling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b071e1c07fd85fba7c2395068ff323a
https://doi.org/10.1158/0008-5472.22430959
https://doi.org/10.1158/0008-5472.22430959
Autor:
Yong Xu, Yuanjie Niu, Ranlu Liu, Yong Wang, Haojie Chen, Yangyi Zhang, Shuo Wang, Shanqi Guo, Xingkang Jiang
Supplementary Table from EIF4A3-Induced circARHGAP29 Promotes Aerobic Glycolysis in Docetaxel-Resistant Prostate Cancer through IGF2BP2/c-Myc/LDHA Signaling
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f53a538b94caa4517198964bb5691f7
https://doi.org/10.1158/0008-5472.22430938
https://doi.org/10.1158/0008-5472.22430938